|
Originally published In Press as doi:10.1074/jbc.M106013200 on July 20, 2001
J. Biol. Chem., Vol. 276, Issue 38, 35571-35580, September 21, 2001
Interleukin-2 Receptor Subunit-dependent and
-independent Regulation of Intestinal Epithelial Tight Junctions*
Raisuke
Nishiyama §,
Takanori
Sakaguchi §,
Tetsushi
Kinugasa ,
Xiubin
Gu ,
Richard P.
MacDermott ¶,
Daniel
K.
Podolsky , and
Hans-Christian
Reinecker
From the Gastrointestinal Unit, Department of
Medicine, Center for the Study of Inflammatory Bowel Disease,
Massachusetts General Hospital & Harvard Medical School, Boston,
Massachusetts 02114 and the ¶ Division of Gastroenterology, Albany
Medical College, Albany, New York 12208
Received for publication, June 28, 2001, and in revised form, July 17, 2001
 |
ABSTRACT |
Interleukin (IL)-15 is able to regulate tight
junction formation in intestinal epithelial cells. However, the
mechanisms that regulate the intestinal barrier function in response to
IL-15 and the involved subunits of the IL-15 ligand-receptor system are
unknown. We determined the IL-2R subunit and
IL-15-dependent regulation of tight junction-associated
proteins in the human intestinal epithelial cell line T-84. The
IL-2R subunit was expressed and induced signal transduction in
caveolin enriched rafts in intestinal epithelial cells. IL-15-mediated
tightening of intestinal epithelial monolayers correlated with the
enhanced recruitment of tight junction proteins into Triton
X-100-insoluble protein fractions. IL-15-mediated up-regulation of ZO-1
and ZO-2 expression was independent of the IL-2R subunit, whereas
the phosphorylation of occludin and enhanced membrane association of
claudin-1 and claudin-2 by IL-15 required the presence of the
IL-2R subunit. Recruitment of claudins and hyperphosphorylated
occludin into tight junctions resulted in a more marked induction of
tight junction formation in intestinal epithelial cells than the
up-regulation of ZO-1 and ZO-2 by itself. The regulation of the
intestinal epithelial barrier function by IL-15 involves
IL-2R -dependent and -independent signaling pathways
leading to the recruitment of claudins, hyperphosphorylated occludin,
ZO-1, and ZO-2 into the tight junctional protein complex.
 |
INTRODUCTION |
The regulation of the intestinal barrier is determined by the
assembly of tight junctions (1). Tight junctions not only create a
primary barrier to prevent paracellular transport of solutes, but they
also restrict the lateral diffusion of membrane lipids and proteins to
maintain cellular polarity (1-4). Tight junctions are macromolecular
assemblies that form a specialized membrane domain at the most apical
region of polarized epithelial cells. Tight junctions have a highly
dynamic structure whose permeability, assembly, and/or disassembly can
be regulated by a variety of cellular and metabolic mediators including
cytokines, which have major functions in the immune system (5-10).
Immune modulators therefore may control tight
junction-dependent intestinal barrier function during
development, wound healing, and pathological processes such as cancer
or chronic inflammation. To date, the claudins (11) and occludin (12,
13) have been identified as tight junction-specific integral membrane
proteins. Occludin and claudins can interact with the PDZ domains of
zonula occludens proteins ZO-1 and ZO-2 (14, 15). ZO-1 and ZO-2 are
membrane-associated guanylate kinase-like homologues
(MAGUKs)1 that may play a
general role in creating and maintaining specialized membrane domains
by cross-linking multiple integral membrane proteins at the cytoplasmic
surface of plasma membranes in various cells types (16-18).
Furthermore, ZO-1 and ZO-2 bind directly to actin filaments at their
COOH-terminal regions, suggesting that these molecules function as
cross-linkers between tight junction strands and actin filaments
(19-22). In addition, ZO-2 has been reported to associate with ZO-1
directly (20, 21). Therefore zonula occludens proteins may establish a
framework to combine the functional components of tight junctions
during the generation of the intestinal barrier.
Disruption of the intestinal epithelial cell barrier function may play
an important role in the pathogenesis of inflammatory bowel disease
(23-25). Although it is not clear whether intestinal barrier
dysfunction is involved in the initiation or is the result of
intestinal inflammation, it is likely that dysfunction of the intestinal barrier would perpetuate intestinal inflammatory responses. Cytokines, which regulate intestinal immune response, may perturb the
intestinal barrier or could contribute to mechanisms that may have
evolved to rapidly seal the intestinal monolayer to limit the influx of
highly antigenic substances into the intestinal lamina propria.
The IL-15 cytokine receptor complex consists of the IL-15R , the
IL-2R , and the c receptor subunit, which is common to several cytokine receptor complexes (26-29). Because the IL-15 receptor complex shares the IL-2R and the c receptor subunits with IL-2, much attention has focused on the overlapping functional effects of
IL-15 and IL-2 in the regulation of T- and B-lymphocytes (26-29). However, the expression of the IL-15R subunit in a wide variety of
different tissues suggests that the functional role of IL-15 is not
limited to the regulation of lymphoid cells (30). Recently IL-15 has
been recognized as a cytokine up-regulated during inflammatory bowel
disease as well as during the colitis in IL-2-deficient mice (31-33).
Nevertheless, it is not clear whether IL-15 contributes to the
perpetuation of inflammation or the regulation of intestinal tissue
repair. Furthermore, IL-15 may be an important regulator of intestinal
intraepithelial lymphocytes. IL-15 is a potent activator of
intestinal intraepithelial lymphocytes (34-36), and the number of
intestinal intraepithelial lymphocytes is reduced in mice lacking the
IL-15R subunit (37).
T-84 cells provide a well established model for the assembly of
intercellular junctions and the development of apical-basolateral polarity (5). T-84 cells express the IL-15R subunit (9) and the
common c receptor subunits (9, 38). However, T-84 cells lack, in
contrast to primary intestinal epithelial cells, the expression of the
IL-2R subunit (9, 38). Nevertheless, T-84 cells respond to
stimulation with IL-15 with an increase in transepithelial electrical
resistance (TER) (9). However, the mechanisms responsible for the
regulation of the intestinal barrier function by IL-15 have not been determined.
To study the regulation of tight junction formation mediated through
the IL-15 ligand receptor system in intestinal epithelial cells, we
stable transfected T-84 cells with IL-2R and characterized the
subsequent basal and IL-15-mediated regulation of tight
junction-associated proteins.
 |
EXPERIMENTAL PROCEDURES |
Cytokines and Antibodies--
Human recombinant IL-15 was
obtained from R & D Systems (Minneapolis, MN). Rabbit polyclonal
antibodies against ZO-1, ZO-2, occludin, claudin-1, and claudin-2 were
from Zymed Laboratories Inc. (San Francisco, CA).
Anti-phosphotyrosine antibody (PY-20) was obtained from Transduction
Laboratories (Lexington, KY). Rabbit polyclonal antibody against the
human IL-2R was from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Blocking antibodies directed against the IL-2R subunit
(MIK1 ) were purchased from Accurate Chemical & Scientific Co.
(Westbury, NY), and control mouse IgG2A was obtained from
Sigma. Fluorescein isothiocyanate-labeled anti-rabbit secondary
antibodies were obtained from Vector Laboratories (Burlingame, CA). For
Western blot analysis, horseradish peroxidase conjugated anti-rabbit or
anti-mouse antibodies were purchased from Amersham Pharmacia
Biotech.
Expression Vector Construction--
To generate an expression
vector encoding the IL-2R subunit, cDNAs encoding extracellular
and intracellular regions were subcloned separately. Reverse
transcriptase-PCR to generate the cDNA for the
NH2-terminal region of the IL-2R subunit was carried out
with reverse transcribed RNA isolated from peripheral blood mononuclear cells with the primer pair 5'-CAG CAC CGG GGA GGA CTG GA-3'
and 5'-CGC CAG GGC TGA AGG ACG AT-3' for 40 cycles at 94 °C for 1 min, 70 °C for 1 min, and 72 °C for 2 min. The PCR product was
cloned into pBluescript KS+ (Stratagene, La Jolla, CA), and the
BamHI/SacI fragment was released for ligation. To generate the COOH-terminal region of the IL-2R cDNA, nested PCR was carried out for 20 cycles at 94 °C for 1 min, 70 °C for 1 min, and 72 °C for 2 min with first sets of primers of 5'-CTG CAA
GGC GAG TTC ACG AC-3' and 5'-AGC AGC AGT GGA GGT TTG GA-3'. A second
PCR was carried out using a 1:100 dilution of the first PCR product as
a template for 30 cycles with the second set of primers (5'-GGC TTT TGG
CTT CAT CT-3' and 5'-AGC TGC AAC TGG ACA CTG AG-3') at 94 °C for 1 min, 70 °C for 1 min, and 72 °C for 2 min. The PCR product was
cloned into pBluescript KS+, and the SacI/XhoI
fragment was released. Extracellular and intracellular parts of
IL-2R cDNA were ligated at the SacI site and ligated into a BamHI/XhoI-digested pcDNA3.1+ vector
(Invitrogen, San Diego, CA). Sequence was confirmed in both directions
using the dideoxy termination method.
Cell Culture and Transfections--
The human colon cancer
derived cell lines T-84 and Caco-2 were obtained from American Type
Culture Collection (Manassas, VA). T-84 cells were grown in Dulbecco's
modified Eagle's medium/Ham's F-12 medium (Cellgro, Mediatech Inc.,
Herndon, VA) with 100 IU/ml penicillin, 100 µg/ml streptomycin, and
10% heat-inactivated fetal calf serum (Sigma) in a humidified 5%
CO2 atmosphere at 37 °C. The cells were transfected
using LipofectAMINE (Life Technologies, Inc.) with 1 µg of
pcDNA3.1+/IL-2R construct. IL-2R subunit stable
transfectants, designated T-84 , were established by selection in
medium supplemented with 1 mg/ml G418 (Life Technologies, Inc.) for 5 weeks.
Cell Proliferation Assay--
T-84 cells and parental T-84
cells were seeded into 96-well plates at a density of 5 × 103 cells/well and were cultured in serum-free Dulbecco's
modified Eagle's medium in the presence of various concentration of
recombinant human IL-15 at 37 °C for 24-72 h. Proliferation was
assessed by MTS assay using CellTiter 96 Aqueous kit (Promega, Madison,
WI) according to the manufacturer's instructions. Each assay was
performed in triplicate. 20 µl of a fresh mixture of MTS tetrazolium
compound and phenazine methosulfate was added to each well and
incubated at 37 °C for 1 h. The amount of formazan corresponds
to the number of viable cells and was measured at an absorbance of 490 nm by an enzyme-linked immunosorbent assay reader. Wells containing medium, but no cells, were subtracted as background from the raw absorbance values.
Measurement of TER--
For sequential TER measurements, T-84
monolayers were maintained on 24-well Transwell collagen-treated
permeable supports (Corning Coster, Cambridge, MA). We determined the
IL-2R -dependent regulation of TER during the assembly of
tight junctions after replating T-84 cells to model the reconstitution
of the intestinal epithelial barrier function during in intestinal
wound healing. T-84 cells were plated at a concentration of 1.5 × 106/well. The cells were stimulated with 100 ng/ml IL-15
24 h later in the presence or absence of anti-IL-2R or control
antibodies, and the TER measurements were carried out at the indicated
time points in triplicate samples. Millicell-ERS epithelial
volt-ohmmeter (World Precision Instruments, New Haven, CT) was utilized
under temperature-controlled conditions at 37 °C with electrodes
reproducibly placed. TER values were calculated by subtracting the
contribution of the bare filter and medium. Statistical analysis was
performed by Student's t test.
Preparation of Triton X-100-soluble and -insoluble Protein
Fractions--
To isolate Triton X-100-soluble and -insoluble protein
fractions, confluent T-84 cell monolayers grown on 10-cm dishes were washed three times with ice-cold PBS, lysed in Triton X-100 buffer (1%
Triton X-100, 100 mM NaCl, 10 mM HEPES, pH 7.6, 2 mM EDTA, 1 mM phenylmethylsulfonylfluoride,
10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 4 mM sodium orthovanadate, 40 mM sodium
fluoride), and then passed through a 21-gauge needle ten times. The
lysates were then centrifuged at 15,000 × g for 30 min
at 4 °C. The resulting supernatant was considered the Triton X-100-soluble fraction. The pellet was solubilized in Triton X-100 buffer containing 1% SDS using an ultrasonic disintegrator, cleared by
centrifugation at 15,000 × g for 5 min at 4 °C, and
referred to as the Triton X-100-insoluble fraction. The protein
concentration of each sample was quantified by the Bradford method.
Isolation of Detergent-insoluble Glycolipid-enriched Membrane
Microdomains--
Glycolipid-enriched membrane microdomains, or
detergent-insoluble glycolipid rafts, were isolated as described before
with minor modifications (39-41). Four dishes of T-84 or T-84 96
cells (diameter, 10 cm) were washed three times with ice-cold PBS, and the cells were solubilized in 1 ml of lysis buffer (25 mM
MES, pH 6.8, 150 mM NaCl, 1% Triton X-100 supplemented
with protease/phosphatase inhibitor mixture). After incubation for 30 min on ice, the lysate was gently processed in a tight fitting Dounce
homogenizer 10 times and cleared by centrifugation for 5 min at
1000 × g. The supernatant was adjusted to 40% sucrose
with an equal volume of 80% sucrose in MBS (25 mM MES, pH
6.8, 150 mM NaCl supplemented with the protease/phosphatase
inhibitor mixture) and transferred to the bottom of a centrifugation
tube. A sucrose step gradient with 30, 25, 20, 15, and 5% in MBS (2 ml
each) was layered on top. After centrifugation in a SW 41 rotor
(Beckman) at 39,000 rpm for 14-16 h at 4 °C, fractions of 1 ml each
were taken, starting from the top and going to the bottom. Protein
measurement of the cellular fractions was performed with BCA protein
assay reagent, according to the manufacturer's instructions (Pierce).
Gel Electrophoresis and Western Blotting Analysis--
The
samples were electrophoresed through a 4-20% gradient
SDS-polyacrylamide gel and transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). After 1 h of blocking
(Tris-buffered saline, 0.1% Tween 20, 1% bovine serum albumin), the
blots were incubated overnight at 4 °C with primary antibodies
diluted in blocking buffer. After washing in Tris-buffered saline,
0.1% Tween 20, the membrane was incubated with appropriate secondary
antibody diluted in blocking buffer for 60 min at room temperature. The hybridized band was detected by an ECL kit (Amersham Pharmacia Biotech)
according to the manufacturer's instructions. Immunoblots were
stripped with 62.5 mM Tris, pH 6.8, 2% SDS containing 10 mM -mercaptoethanol at 50 °C for 30 min.
RNA Extraction and Northern Blot Analysis--
Total RNA was
isolated from cultured cells using Trizol reagent (Life Technologies,
Inc.). Thirty micrograms of total RNA were electrophoresed in a 1%
agarose formaldehyde gel and then transferred onto a nylon membrane
(Magna NT, MicroSeparations Inc., Westbrough, MA) by capillary
blotting. The probes were labeled with [ -32P]dCTP
using the Rediprime Random Primer Labeling Kit (Amersham Pharmacia
Biotech). Membranes were hybridized with radiolabeled cDNA probes
in Quickhyb solution (Stratagene, La Jolla, CA) at 65 °C for 1 h. The membranes were washed with 1% SDS, 2× sodium chloride sodium
citrate buffer. The blots were analyzed by autoradiography. The blots
were sequentially hybridized with IL-15 and glyceraldehyde-3-phosphate dehydrogenase probes as described previously (42).
Confocal Microscopy--
T-84 and T-84 96 cells were grown for
3 days with or without 100 ng/ml IL-15 on chamber slide culture
chambers (Nunc Inc., Naperville, IL). T-84 cells or T-84 96 cells
were washed three times with Dulbecco's PBS (Life Technologies, Inc.)
and were fixed for 10 min in 2% paraformaldehyde for immunostaining
with antibodies recognizing occludin or for 30 s in aceton at
20 °C for the detection of claudin-1, claudin-2, ZO-1, and ZO-2.
Thereafter, the cells were blocked with 1:200 PBS-diluted normal donkey
serum for 1 h at 20 °C and incubated with 1:200 in PBS-diluted
primary antibodies overnight at 4 °C. After three washes with PBS,
the monolayers were incubated at room temperature with anti-mouse or
anti-rabbit IgG fluorescein isothiocyanate-conjugated antibody (1:500
in PBS) for 1 h in the dark at room temperature and analyzed with
a confocal immunofluorescent microscope (Bio-Rad).
 |
RESULTS |
Stable Transfection with the IL-2R Subunit Initiates the
Concentration-dependent Autocrine Activation of
Phosphotyrosine Kinases in T-84 Cells--
An initial screen of 98 IL-2R -transfected T-84 clones yielded two clones with a high
expression of functional IL-2R subunits. The low number of stable
transfected clones reflects the difficulties in stably transfecting
T-84 cells. Both IL-2R subunit expressing T-84 cell clones
(T-84 29 and T-84 96) exhibited a similar phenotype and were
characterized by an increased resistance to separation by a 1 mM EDTA, 0.25% trypsin solution. T-84 29 and T-84 96
monolayers required 15-20 min of incubation to obtain single-cell
suspensions instead of the 5-7 min of incubation time required for the
parental T-84 monolayers. Both T-84 29 and T-84 96 cells form
uniform, tightly packed monolayers within 3 days after separation at a 1:4 split ratio.
Expression levels and membrane targeting of the IL-2R subunit in
stable transfected T-84 cells was analyzed in Triton X-100-soluble and
-insoluble protein fractions (Fig.
1A). As demonstrated in Fig.
1A, T-84 29 and T-84 96 cells expressed the IL-2R
subunit, whereas the IL-2R chain was not detectable in parental T-84
cells. When analyzed densitometrically, the expression of the IL-2R was 3-fold higher in T-84 29 cells than in T-84 96 cells (Fig. 1A). In both T-84 29 and T-84 96 cells, the IL-2R
subunit was highly enriched in Triton X-100-insoluble protein
fractions, demonstrating that the stable expressed cytokine receptor
was integrated into T-84 cell membranes (Fig. 1A).

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 1.
Expression of the IL-2R
subunit induces activation of phosphotyrosine kinases in T-84
cells. Western blot analysis of 1% Triton X-100-soluble
(S) and -insoluble (P) protein fractions from
T-84 cells and IL-2R expressing T-84 29 or T-84 96 cells is
shown. Each lane was loaded with 10 µg of protein and
resolved by SDS-polyacrylamide gel electrophoresis in a 4-20%
Tris-glycine gel. The blot was probed with specific antibodies for the
IL-2R subunit (1:500) in A and with anti-phosphotyrosine
antibodies ( -P-Tyr, 1:2000) in B.
|
|
Overexpression of cytokine receptors may lead to autonomous activation
of signal transduction events. Therefore, we determined the basal
activation of tyrosine phosphorylation in parental T-84 cells,
T-84 29, and T-84 96 cells. As demonstrated in Fig. 1B, T-84 29 cells demonstrated an enhanced basal level of phosphotyrosine kinase activity compared with the parental T-84 cells and T-84 96 cells when membrane-associated Triton X-100-insoluble protein fractions
were analyzed (Fig. 1B, lane 4 compared with
lanes 2 and 6). The elevation of tyrosine
phosphorylation in the T-84 29 cells correlated with the high level
of IL-2R subunit expression in Triton X-100-insoluble membrane
fraction in this T-84 cell clone.
The IL-2R Subunit Transduces IL-15-mediated Signals in
Caveolin-1-enriched Detergent-insoluble Glycolipid-enriched Membrane
Microdomains in T-84 Cells--
To further characterize the membrane
compartment containing the IL-2R subunit, we separated postnuclear
membrane protein fractions by sucrose density gradient centrifugation.
This method separates detergent-insoluble membrane fractions
characterized by their specific lipid composition (40, 43, 44). As
demonstrated in Fig. 2A, the
IL-2R subunit was present in low sucrose gradient fractions of
T-84 96 cells. IL-2R was present in membrane fractions corresponding to sucrose concentrations of 20-24%, with the highest concentration in the 20% sucrose gradient fraction (Fig.
2A). These low sucrose gradient fractions have been
associated with detergent-insoluble glycolipid-enriched membrane
fractions or rafts (45). In epithelial cells, these membrane fractions
are characterized by the presence of the scaffolding protein caveolin (46). As demonstrated in Fig. 2A, Western blot analysis of
these cellular compartments revealed that the expression of caveolin-1 was restricted to the same sucrose gradients as that of the
IL-2R .

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of the IL-2R
subunit is targeted to caveolin-1 containing
detergent-insoluble glycolipid-enriched membrane microdomains.
A demonstrates the immunoblot analysis of IL-2R subunit
expression in T-84 96 cell membrane fractions separated by sucrose
gradient centrifugation layered on top of the T-84 cell lysate,
containing 1% Triton X-100. The sucrose concentrations of relevant
fractions are indicated. Equal amounts of protein were subjected to
Western blot analysis as described under "Experimental Procedures."
The same blot was stripped and rehybridized with antibodies directed
against caveolin-1. In B, T-84 96 cells or parental T-84
cells were stimulated with or without 100 ng/ml IL-15 for 15 min, and
Triton X-100-insoluble membrane fractions were prepared in sucrose
gradients and resolved by SDS-polyacrylamide gel electrophoresis, and
tyrosine phosphorylation of proteins was analyzed by Western blotting
(5 µg of protein/lane).
|
|
In the next set of experiments, we determined whether the expression of
the IL-2R subunit enhanced the responsiveness of T-84 cells to
IL-15. In these experiments, we used T-84 96 cells, which had a
base-line activation of phosphotyrosine kinase comparable with T-84
cells (Fig. 1B). T-84 and T-84 96 cells were cultured for
15 min with or without IL-15. As demonstrated in Fig. 2B, IL-15 stimulation was able to induce a strong up-regulation of phosphotyrosine kinase activity in T-84 96 cells after 15 min (Fig.
2B, lane 10). IL-15 induced tyrosine
phosphorylation of proteins with a molecular mass of 100 kDa, as
well as a number of proteins with molecular masses between 42 and 54 kDa in T-84 96 cells (Fig. 2B, lane 10). In
contrast, IL-15 induced only a weak tyrosine phosphorylation of
proteins in the parental T-84 cell line, which had a molecular mass of
160 kDa in the 20% sucrose gradient fraction and of 150 kDa in the
32-38% sucrose gradient fractions (Fig. 2B, lanes
10 and 14-16). The majority of the proteins that were
tyrosine-phosphorylated in response to IL-15 migrated with membrane
proteins of the 20% sucrose gradient (Fig. 2B, lanes 2 and 10), which corresponds to the same membrane
fraction in which the IL-2R subunit was enriched in T-84 96 (Fig.
2A). Collectively, these data indicate that the IL-2R
subunit stable expressed in T-84 cells constitutes a functional IL-15
receptor. The IL-2R subunit is largely sequestered and initiates
signal transduction in a microdomain of T-84 cell membranes that
display the biophysical characteristics of caveolae (45).
Expression of the IL-2R Subunit Enhances the Development of
Transepithelial Electrical Resistance and Renders T-84 Cells Responsive
to IL-15--
The assembly of tight junctions is correlated with the
development of TER across T-84 intestinal epithelial monolayers.
Increased cell-cell adhesion of the T-84 29 and T-84 96 cells
suggested enhanced formation of adherens and tight junctions.
Furthermore, IL-15 has been identified as a regulator of TER in T-84
cells (9). We therefore compared the development of TER in T-84 96 and parental T-84 cells. As demonstrated in Fig.
3A, T-84 96 cells developed
a higher steady state TER than the parental T-84 cells. The TER of
T-84 96 cells increased 26 ± 4% within 2 days after reaching
confluence. In contrast, the TER of the parental T-84 cells increased
only 4 ± 3% in the same time period (*, p < 0.001; Fig. 3A). Overall, the TER of the parental T-84 cells
increased 9 ± 4% over the 4-day observation period,
significantly below the increase in TER of 29+3% observed in the
T-84 96 cells (^, p < 0.005; Fig. 3A).
In the presence of anti-IL-2R antibody, TER of T-84 96 cells
increased only 12 ± 3% over 2 days, whereas the control
IgG-treated T-84 96 cells reached steady state TER with an increase
of 26 ± 4% over the same time period (+, p < 0.01; Fig. 3A). The assembly of tight junctions with the
subsequent development of TER in T-84 96 cells was enhanced by
exogenous IL-15. In the presence of IL-15, T-84 96 cells reached
steady state TER levels 24 h earlier (30 ± 4% increase)
than unstimulated T-84 96 cells, which increased their TER 12 ± 4% within 24 h after reaching confluence (¶,
p < 0.001; Fig. 3A). The addition of IL-15 to the parental T-84 cells increased the TER 15 ± 3%, compared with an increase of 8 ± 4% of unstimulated T-84 cells within the observed time period (Fig. 3A). As demonstrated in Fig.
3B, T-84 and T-84 96 cells did not differ in their
proliferation rate in the presence or absence of IL-15.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
IL-2R subunit
expression enhances the development of transepithelial electrical
resistance and renders T-84 cells responsive to IL-15. A,
the development of TER. 1.5 × 106 T-84 96 cells
(open symbols) or parental T-84 cells (closed
symbols) were seeded onto permeable supports. Either 100 ng/ml
IL-15 (circles), 10 µg/ml blocking anti-IL-2R antibody
(upward triangle), or 10 µg/ml control IgG2A
(downward triangle) were added to the basolateral
compartment 24 h after seeding. Development of TER was measured by
standard methods (see "Experimental Procedures"). The data were
obtained from triplicate samples. One representative experiment of
three carried out with similar results is presented. ¶,
p < 0.001; , p < 0.005;
*, p < 0.001; +,
p < 0.01. B, cell proliferation of T-84 and
T-84 96 cells. 5 × 103 T-84 96 or parental T-84
cells were cultured in 96-well plates without (open bars) or
with addition of 100 ng/ml of IL-15 (hatched bars). The
proliferation was determined by MTS assay in triplicate samples as
outlined under "Experimental Procedures." One representative
experiment of three carried out with similar results is presented.
C, Northern blot analysis of IL-15 and
glyceraldehyde-3-phosphate dehydrogenase mRNA expression in
T-84 96 (lanes 1-7) and T-84 cells (lanes
8-14) without or with 100 ng/ml IL-15 for the indicated time
periods. Caco-2 cell RNA harvested 72 h after replating was used
as a positive control (lane 15).
|
|
Furthermore, the regulation of tight junction formation in T-84 and
T-84 96 cells was not due to the expression of IL-15 by the
intestinal monolayers themselves. As demonstrated in Fig. 3C, parental T-84 cells express very small amounts of IL-15
mRNA during the observed time period in comparison with Caco-2
cells. Furthermore, only the larger of the two IL-15 isoform
transcripts was detectable in T-84 cells (Fig. 3C). IL-15
mRNA expression was not detectable in the T-84 96 cells (Fig.
3C). Most importantly, IL-15 stimulation of either T-84 cell
line did not induce IL-15 mRNA expression (Fig. 3C).
These data suggest that the basal regulation of TER in T-84 96 cells
may be mediated by low level of autonomous signaling of the
overexpressed IL-2R . In addition, IL-2R subunit expression
enhanced the biological response to the exogenous IL-15 stimulation in
T-84 96 cells.
Expression of the IL-2R Subunit in T-84 Cells Regulates
Expression and Membrane Association of Tight Junction
Proteins--
Assembly of tight junctions is associated with the
development of resistance of tight junction protein complexes to
solubility in detergent-salt extractions. Conversely, disassembly of
tight junction proteins has been shown to correlate with
internalization or diffuse cytoplasmic distribution of tight junction
proteins, making them more extractable with detergent-salt solutions.
Therefore, the solubility of tight junction proteins can be used as an
indicator of membrane and cytoskeletal association (47-49). Moreover,
an increased insoluble:soluble ratio of tight junction proteins can be
correlated with an increase in transepithelial resistance (50). To
determine the expression of tight junction-associated proteins in T-84,
T-84 29, and T-84 96 cells, we carried out Western blot analysis of
transmembrane proteins claudin-1, claudin-2, and occludin and the MAGUK
family members ZO-1 and ZO-2 in Triton X-100-insoluble and -soluble
protein fractions.
Transmembrane tight junctional proteins and zonula occludins
demonstrated a differential distribution in Triton X-100-soluble and
-insoluble protein fractions in T-84 cells. As demonstrated in Fig.
4 A-C, claudin-2 and ZO-1
were enriched in the Triton X-100-insoluble protein fractions, whereas
claudin-1 was enriched in the Triton X-100-soluble protein fraction in
T-84, T-84 29, and T-84 96 cells. ZO-2 was highly enriched in
Triton X-100-soluble fractions in T-84 and T-84 96 cells, whereas in
T-84 29 cells, ZO-2 was enriched in the Triton X-100-insoluble
protein fractions (Fig. 4, A-C). Furthermore, ZO-2
expression was 2-fold increased in Triton X-100-insoluble protein
fraction and decreased 2.5-fold in the soluble fraction when compared
with T-84 and T-84 96 (Fig. 4, A and C). In
addition, claudin-1 and claudin-2 expression was increased in Triton
X-100-soluble and -insoluble protein fractions of T-84 29 cells, when
compared with T-84 and T-84 96 cells (Fig. 4, A and
B). Compared with T-84 cells, claudin-1 expression was increased 1.45-fold in soluble and 1.35-fold in insoluble protein fractions of T-84 29. Claudin-2 expression increased 2-fold in soluble and 1.4-fold in insoluble protein fractions in T-84 29 cells
in comparison with the parental T-84 cells (Fig. 4, A and B).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of the
IL-2R subunit regulates expression of tight
junction-associated proteins in T-84 cells. A, Western blot
analysis of 1% Triton X-100-soluble (S) and -insoluble
(P) protein fractions from T-84 cells, T-84 29 and
T-84 96 cells isolated from confluent monolayers 5 days after
replating. Immunoblots were hybridized with antibodies specific for
claudin-1, claudin-2, occludin, ZO-1, and ZO-2. 10 µg of protein/lane
was analyzed. The Western blots shown in A were quantitated
with NIH Image 1.61 image analysis software, and the corresponding
results are shown for claudin-1 and claudin-2 in B, for ZO-1
and ZO-2 in C, and for occludin and hyperphosphorylated
occludin in D.
|
|
The anti-occludin antibodies detected a low molecular mass species
(65-71 kDa) in soluble protein fractions and a high molecular mass
species (72-79 kDa) in insoluble protein fractions in T-84 cells that
have been recognized as hyperphosphorylated forms enriched in tight
junctions (Fig. 4A) (49, 51, 52). Nonphosphorylated and
phosphorylated basal occludin levels were comparable in T-84, T-84 29, and T-84 96 cells (Fig. 4, A and D).
As demonstrated in Fig. 4 (A and D),
phosphorylated occludin was almost exclusively detected in the Triton
X-100-insoluble protein fraction in T-84, T-84 29, and T-84 96
cells. Therefore, the preferential expression of claudin-1 and ZO-2 in
the Triton X-100-soluble protein fraction suggests an expression of
both proteins in membrane or cellular compartments distinct from tight
junctions. Enhanced expression of claudins and redistribution of ZO-2
from Triton X-100-soluble into -insoluble protein fractions correlated
with the higher expression of the IL-2R in the T-84 29 cell line.
IL-15 Regulates the Expression and Membrane Association of Tight
Junctional Proteins by IL-2R -dependent and -independent
Mechanisms--
The regulation of claudin-2 and ZO-2 expression in
T-84 29, which are characterized by a high expression of IL-2R ,
suggested that signals mediated through the IL-2R may be able to
regulate the intestinal barrier through modulation of the expression
and the cellular distribution of tight junction-associated proteins. We
therefore assessed the effect of IL-15 on expression and membrane association of tight junctional proteins in T-84 and T-84 96 cells. T-84 cells or T-84 96 cells were stimulated with IL-15 (100 ng/ml) 1 day after replating and harvested after 24, 48, and 72 h. Triton X-100-insoluble and -soluble protein fractions were prepared to determine the expression and membrane association of tight
junction-associated proteins in stimulated or unstimulated T-84 and
T-84 96 cells. In T-84 96 cells, IL-15 enhanced expression of
claudin-1 and claudin-2 in Triton X-100-insoluble membrane fractions
within 3 days 1.8 ± 0.17- and 1.9 ± 0.15-fold,
respectively, compared with unstimulated cells (Fig.
5, A-C). In contrast,
recruitment of claudin-1 and claudin-2 into Triton X-100-insoluble
membrane protein fraction was not altered by IL-15 within the same time
period in parental T-84 cells (Fig. 5, A-C). In the absence
of IL-15, claudin-1 and claudin-2 remained almost constant over the
observed time period in both cell lines. As demonstrated in Fig. 5
(A, D, and E), IL-15 induced a
1.9 ± 0.13-fold increase in nonphosphorylated occludin in Triton
X-100-insoluble fractions of T-84 96 cells.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
IL-15 regulates the expression of tight
junction-associated proteins in intestinal epithelial cells.
A, Western blot analysis of 1% Triton X-100-soluble
(S) and -insoluble (P) protein fractions over a
3-day period from nonstimulated or IL-15 (100 ng/ml) stimulated T-84
cells and T-84 96 cells is shown. Immunoblots were hybridized with
antibodies specific for claudin-1, claudin-2, occludin, ZO-1, and ZO-2.
5 µg of protein/lane was analyzed. Expression of tight
junction-associated proteins in Triton X-insoluble protein fraction
of T-84 cells and T-84 96 cells was analyzed densitometrically and
expressed as mean density/area in B for claudin-1, in
C for claudin-2, in D for occludin, in
E for hyperphosphorylated occludin, in F for
ZO-1, and in G for ZO-2. *, p < 0.01, **,
p < 0.05, in comparison with unstimulated cells; #,
p < 0.01, in comparison with day 1 of measurement;
both as determined by Student's t test.
|
|
Furthermore, IL-15 induced a 1.5 ± 0.1-fold increase after 1 day
and a 2.1 ± 0.16-fold increase of phosphorylated occludin species
after 3 days in the Triton X-100-insoluble fractions in T-84 96
cells. In T-84 cells the expression of nonphosphorylated occludin
increased 1.3 ± 0.12-fold over the 3-day observation period.
IL-15 did not further increase occludin expression in the parental T-84
cell line (Fig. 5, A and D). In contrast to the
regulation of transmembrane tight junctional proteins, recruitment of
ZO-1 and ZO-2 into the Triton X-100-insoluble protein fraction in T-84
cells was enhanced by IL-15 independent of the expression of the
IL-2R chain. As demonstrated in Fig. 5 (A, F,
and G), after replating without IL-15 stimulation, ZO-1 and
ZO-2 levels in the Triton X-100-insoluble fractions decreased in T-84
cells 0.77 ± 0.1- and 0.8 ± 0.08-fold, respectively. In
T-84 96 cells, ZO-2 levels in the Triton X-100-insoluble protein
fraction decreased 0.63 ± 0.09-fold, whereas ZO-1 levels appeared
to be unaltered over the 3-day observation period (Fig. 5,
A, F, and G). In both T-84 and
T-84 96 cells, IL-15 was able to induce the expression and membrane
association of ZO-1 and ZO-2. In T-84 cells, IL-15 increased the ZO-1
and ZO-2 levels in Triton X-100-insoluble protein fractions 1.4 ± 0.11-fold. In T-84 96 cells, ZO-1 levels increased 1.6 ± 0.17-fold, and ZO-2 levels increased 1.5 ± 0.13-fold in response
to IL-15. Whereas ZO-2 membrane association was regulated by IL-15, the
available pool of ZO-2 in the cytoplasm was not altered in T-84 and
T-84 96 cells (Fig. 5A).
In the next set of experiments, we determined the expression and
membrane association of claudin-1 and claudin-2, occludin, ZO-1, and
ZO-2 by Z-section confocal microscopy in T-84 and T-84 96 cells. In
these experiments T-84 and T-84 96 cells were stimulated with IL-15
for 3 days, and fixed, and stained for the presence of tight
junction-associated proteins. As demonstrated in Fig. 6, IL-15 increased the recruitment of
claudin-1 and claudin-2 into tight junctional complexes in T-84 96
cells (B compared with A, and F
compared with E) but not in the parental T-84 cells
(C, D, G, and H).
IL-15-induced signals also regulated the recruitment of occludin into
the area of tight junctions in T-84 96 cells (Fig. 6, compare
J with I) but not in the parental T-84 cells (Fig. 6, K and L). In contrast IL-15 induced the
recruitment and integration of ZO-1 and ZO-2 into tight junctions in
T-84 96 as well as the parental T-84 cells (Fig. 6, M-T).
Claudin-2, occludin, ZO-1, and ZO-2 immunostaining reached further down
the lateral cell contact areas after stimulation with IL-15, suggesting
the expansion of tight junctional contact areas. In contrast, claudin-1 immunostaining appeared to be recruited into the apical portion of cell
contacts, suggesting a distinct role of claudin-1 and claudin-2 in the
structuring of tight junctional protein complexes. In T-84 96 cells,
IL-15 also increased the cytoplasmic staining for tight
junction-associated proteins. In agreement with the Western blot
analysis, ZO-2 was present constitutively in the cytoplasm of T-84 96
and T-84 cells (Fig. 6, Q-T).

View larger version (122K):
[in this window]
[in a new window]
|
Fig. 6.
IL-15 regulates the subcellular
distribution of tight junction-associated proteins dependently or
independently of IL-2R subunit. Shown are
Z section confocal microscopy of tight junction-associated proteins in
T-84 and T-84 96 cell monolayers cultured with or without 100 ng/ml
of IL-15 for 3 days and immunostaining for claudin-1 (A-D),
claudin-2 (E-H), occludin (I-L), ZO-1
(M-P), and ZO-2 (Q-T). The white
bars correspond to 10 µM.
|
|
 |
DISCUSSION |
Characterization of the IL-2R subunit overexpressing T-84 cell
lines revealed that the assembly of tight junctions by IL-15 is
mediated by the differential regulation of the expression and membrane
association of tight junction-associated proteins. In our experiments,
IL-15 was able to regulate the expression and membrane association of
claudins, hyperphosphorylated occludin, ZO-1, and ZO-2 in human
intestinal epithelial cells during the formation of the intestinal
epithelial barrier. Furthermore, the involved mechanisms can be
distinguished based on their requirement for the presence of the
IL-2R subunit in intestinal epithelial cells.
Expression of the IL-2R subunit strongly up-regulated the
development of TER in the human intestinal epithelial cell line T-84.
The assembly of tight junctions with the subsequent development of TER
in T-84 96 cells could be further enhanced by exogenous IL-15,
indicating that the substitution of the IL-2R subunit in T-84 cells
reconstituted a functional IL-15 receptor complex. The assembly of
tight junctions in T-84 96 was blocked by the addition of
anti-IL-2R antibodies, suggesting that expression of the IL-2R
subunit in T-84 cells resulted in constitutive activation of the
receptor. This constitutive activation did not result in the induction
of cell proliferation in T-84 96 cells, nor did the expression of
IL-2R mediate cell proliferation in response to IL-15 stimulation.
These data suggest that the functional effects of signal transduction
of the IL-15 receptor in T-84 96 cells may differ from those observed
in lymphocytes, where reconstitution of a complete IL-15 receptor
complex results in induction of cell proliferation (30). Alternatively,
contact inhibition of T-84 proliferation may overcome signals mediated
through the IL-15 receptor because intestinal epithelial cell lines
with reduced contact inhibition are able to proliferate in response to
IL-15 (42).
The IL-2R subunit was expressed and initiated signal transduction
events in detergent-insoluble glycolipid-enriched membrane microdomains
or rafts in T-84 cells. In these rafts, the IL-2R subunit
co-isolated with caveolin-1, a scaffolding protein abundant in
detergent-insoluble glycolipid rafts. Similar isolated protein membrane
fractions were recently shown to contain phosphorylated occludin and
ZO-1 (49). These findings led to the hypothesis that tight junctions
themselves have a raftlike membrane compartment that is characterized
by the presence of caveolin-1. However, evidence is mounting that
detergent-insoluble glycolipid rafts in intestinal epithelial cells are
heterogenous and may include membrane microdomains, which do not
contain caveolin-1 (53). Therefore, it is currently not clear whether
signal transduction mediated through the IL-2R subunit can lead to
the direct activation of tight junction-associated proteins in the same
raftlike membrane compartments.
The development of intestinal barrier function correlated with the
induction of tyrosine phosphorylation in T-84 96 cells. IL-15 induced
tyrosine phosphorylation in T-84 as well as T-84 96 cells. Changes in
phosphotyrosine kinase activity have been linked to the regulation of
tight junctions (54). Tyrosine phosphorylation of proteins may be
involved in both the establishment and the disassembly of tight
junctions. Tyrosine phosphorylation has been demonstrated to play an
important role in the reassembly of occludin and other tight junction
proteins during ATP repletion (55). Tyrosine phosphorylation of ZO-1
and other proteins occurred during the formation of podocyte junctions
in glomeruli (56). Furthermore, epidermal growth factor stimulation
caused a transient increase in tyrosine phosphorylation of both ZO-1
and ZO-2 in A431 cells (54). Recently, the tyrosine phosphorylation of
occludin and ZO-1 has been linked to the regulation of tight junction
formation in Ras-transformed MDCK cells (50). However, tyrosine
phosphorylation of both ZO-1 and ZO-2 induced by v-Src did not change
either tight junction structure or TER (57). In contrast, the
protein-tyrosine phosphatase inhibitors vanadate and
H2O2 resulted in a rapid increase in
paracellular permeability and the redistribution of E-cadherin and ZO-1
in MDCK cells (58). Similarly, inhibition of tyrosine phosphatases by
sodium pervanadate resulted in a decrease in TER in both MDCK cells and
brain endothelial cells (59).
The regulation of tight junction-associated proteins by cytokines is
not well understood. We recently demonstrated that immune modulators
regulate tight junction formation in human intestinal epithelial cells
by regulating the expression of the claudin family of proteins (10).
Furthermore, recent observations demonstrated that claudin-1 and ZO-1
isolate in Triton X-100-insoluble membrane compartments during tight
junction formation in Ras-transformed MDCK cells (50).
Our data indicate that claudin-1 and claudin-2 may localize into
different, partially overlapping, cellular compartments within T-84
cells and, therefore, may have distinct functions in the regulation of
cellular junctions. Whereas claudin-1 was mostly detected in Triton
X-100-soluble protein fractions, claudin-2 was highly enriched in tight
junctional protein fractions characterized by the expression of
hyperphosphorylated occludin in T-84 cells. Both proteins were
recruited into Triton X-100-insoluble protein fractions upon induction
of tight junction formation in T-84 96 cells by IL-15. However,
claudin-1 was recruited to the apical pole of cell-cell contacts,
whereas claudin-2 positive staining was observed in a larger lateral
apical membrane compartment.
The enhanced expression of claudins in tight junctions by IL-15 was
dependent on the presence of the IL-2R subunit. Claudins are a
multigene family consisting of at least 24 members (60). Claudin-1 and
claudin-2 have the ability to induce the formation of networks of
strands and grooves at cell-cell contact sites when introduced into
fibroblasts lacking tight junctions (11), and their increased
expression correlates with the tightening of the paracellular barrier
in human intestinal epithelial cells (10). Increasing evidence suggests
that claudin expression is tissue type-specifically regulated (61).
Expression of claudin proteins in primary tissues has been demonstrated
for claudin-1, -2, -3, -4, and -8 in kidney and liver tissues (11, 62).
Claudin-5 has been demonstrated to be a component of tight junctions in endothelial cells (63), and claudin-11 expression has been demonstrated in tight junctions of sertoli cells and brain myelin sheets (61, 63).
Furthermore, the kidney epithelial cell line MDCK preferably expresses
claudin-1 and claudin-4 but little claudin-2 and claudin-3 (64),
whereas the human intestinal epithelial cell line T-84 is able to
express both claudin-1 and claudin-2 in tight junctional complexes
(10).
The high TER induced by IL-15 in T-84 96 cells correlated with
up-regulation of membrane-associated hyperphosphorylated occludin by IL-15. Occludin is a transmembrane protein within tight junctions (12), and it plays an essential role in the formation of the tight
junction paracellular permeability barrier (65, 66). Formation of tight
junctions in MDCK cells has been shown to correlate with
serine/threonine as well as tyrosine phosphorylation of occludin, resulting in a number of occludin proteins migrating as 70-82-kDa bands on SDS-polyacrylamide gel electrophoresis (50-52). Furthermore, highly phosphorylated occludin was found to be selectively concentrated at tight junctions, whereas less or nonphosphorylated occludin localized within the cytoplasm and to the basolateral membrane of MDCK
cells and T-84 cells (49, 51, 52). How phosphorylation of occludin is
regulated and which kinases are involved in the activation process
leading to the assembly of tight junctions is not known. Among the
analyzed tight junction-associated proteins, only phosphorylated
occludin was significantly up-regulated after 1 day of IL-15
stimulation in T-84 96 cells. At this time point T-84 96 cells
demonstrated the highest difference in TER in comparison with the
parental T-84 cells, suggesting that phosphorylation of occludin may
tighten the paracellular barrier. Alternatively, additional unknown
components of tight junctions may be regulated by IL-15 in T-84 96
cells. Together, our data suggest that IL-15 may be able to regulate
intestinal epithelial cell barrier function through the combined
regulation of occludin expression and phosphorylation.
Whereas the regulation of claudins and occludin by IL-15 was only
observed in the T-84 96 cell line, the regulation of the membrane
association of ZO-1 and ZO-2 was independent of the IL-2R subunit.
ZO-1 and ZO-2 interact with occludin and claudins through their PDZ
domains. These interactions are predicted to stabilize a network of
tight junctional protein complexes and the cytoskeleton (19-22). Our
data demonstrate that ZO-1 and ZO-2 have a different cellular
distribution in T-84 cells. ZO-1 was enriched together with claudin-2
and hyperphosphorylated occludin in Triton X-100-insoluble protein
fractions, whereas ZO-2 was detected at high levels in the soluble
protein fraction, which contained most of claudin-1. It remains to be
determined whether the differential expression of claudin-1 together
with ZO-2 and claudin-2 with ZO-1 is due to direct interaction of these proteins.
After replating of T-84 cells, expression of the initial high protein
levels of ZO-1 and ZO-2 decreased over a 3-day period, whereas in the
presence of IL-15, the recruitment of both proteins into the Triton
X-100-insoluble membrane fraction was enhanced. The recruitment and
phosphorylation of ZO-1 in Triton X-100-insoluble protein fractions
during the formation of tight junctions has been recently demonstrated
in MDCK cells (50). In contrast, the role of ZO-2 in tight junction
formation is not well characterized. Our data indicate that T-84 may
express ZO-2 in cellular compartments distinct from tight junctions. In
these compartments, ZO-2 may have additional functions, possibly in the
regulation of adherens junction in intestinal epithelial cells, because
ZO-1 as well as ZO-2 can localize to adherence junctions in a number of
different cell types (21). The regulation of ZO-1 and ZO-2 by IL-15 was observed in both parental T-84 cells and the IL-2R subunit
expressing T-84 cell lines and therefore may be mediated by the
IL-15R and c alone as proposed for the IL-15 receptor complex on
mast cells (67). Alternatively, IL-15 or its receptor complex may be
able to interact with additional receptors expressed in intestinal epithelial cells. One alternative receptor for IL-15 may include the
epithelial cell kinase (Eck) receptor, which can be activated not only
by its specific ligand B61 but also by different additional mediators,
which include IL-15 (68). Activation of the Eck correlates with
tightening of the paracellular barrier in the human intestinal epithelial cell line Caco-2 (68). The IL-15-mediated regulation of ZO-1
and ZO-2 was independent of the IL-2R subunit, whereas the
phosphorylation of occludin and enhanced membrane association of
claudins by IL-15 required the presence of the IL-2R subunit. Therefore, the recruitment of intracellular zonula occludin proteins into tight junctions may be able to regulate the epithelial barrier function independently from the induction of the expression of transmembrane tight junctional proteins. Moderate increases in TER may
be achieved by the enhanced recruitment of ZO-1 and ZO-2 into tight
junctional complexes, but strong induction of intestinal barrier
function may require the parallel induction of occludin and claudin
protein expression. The IL-2R subunit-independent regulation of
recruitment of ZO-1 and ZO-2 into Triton X-100-insoluble membranes by
IL-15 may explain why untransfected T-84 cells are able to up-regulate
their TER (9).
IL-15 and IL-15R mRNA expression has been detected in numerous
tissues, many of which are not sites of immune responses, indicating
the potential for additional nonimmune functions (26). In inflammatory
bowel disease, elevated IL-15 expression derived from peripheral
blood mononuclear cells, intestinal macrophages, or intestinal
epithelial cells has been associated with disease stages (31, 32, 69).
Furthermore, IL-15 mRNA is expressed at high levels in normal and
diseased mouse intestine (70) and up-regulated during intestinal
inflammation in IL-2-deficient mice. Our data indicate that IL-15, in
addition to its ability to regulate intestinal NK-cells, dendritic
cells, and intraepithelial lymphocyte populations (37), is also a
cytokine able to regulate the intestinal barrier function.
The broad pleiotropic effects of IL-15 on multiple tissues and cell
types outside of the classical immune system are unusual for a
cytokine, and further understanding of how IL-15 may affect nonimmune
cells could provide information relevant to the understanding of the
role of IL-15 in the regulation of inflammation and wound healing.
Together, our experiments support a model in which IL-15 functions to
regulate the expression and membrane association of tight
junction-associated proteins during the formation of the intestinal
barrier. Distinct IL-15-initiated signaling pathways can mediate either
the recruitment of MAGUK family members into tight junctional complexes
or the enhanced expression and membrane association of transmembrane
tight junctional proteins.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK 51003 and DK 54427 (to H.C.R.), DK 21474 (to R. P. M.), DK 41557 (to D. K. P.), DK 43351 (to H. C. R.,
D. K. P., and R. P. M.), and PO1 DK 33506 (to
H. C. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
To whom correspondence should be addressed: Gastrointestinal
Unit, Jackson Bldg. R711, Massachusetts General Hospital, 32 Fruit St.,
Boston, MA 02114. E-mail:
reinecker@helix.mgh.harvard.edu.
Published, JBC Papers in Press, July 20, 2001, DOI 10.1074/jbc.M106013200
 |
ABBREVIATIONS |
The abbreviations used are:
MAGUK, membrane-associated guanylate kinase-like homologue;
IL, interleukin;
TER, transepithelial electrical resistance;
PCR, polymerase chain reaction;
PBS, phosphate-buffered saline;
MES, 4-morpholineethanesulfonic acid;
MDCK, Madin-Darby canine
kidney.
 |
REFERENCES |
| 1.
|
Madara, J.
(1998)
Annu. Rev. Physiol.
60,
143-159
|
| 2.
|
Schneeberger, E. E.,
and Lynch, R. D.
(1992)
Am. J. Physiol.
262,
L647-L661
|
| 3.
|
Gumbiner, B. M.
(1993)
J. Cell Biol.
123,
1631-1633
|
| 4.
|
Anderson, J. M.,
and Van Itallie, C. M.
(1995)
Am. J. Physiol.
269,
G467-G475
|
| 5.
|
Madara, J. L.
(1988)
Cell
53,
497-498
|
| 6.
|
Nusrat, A.,
Parkos, C. A.,
Bacarra, A. E.,
Godowski, P. J.,
Delp-Archer, C.,
Rosen, E. M.,
and Madara, J. L.
(1994)
J. Clin. Invest.
93,
2056-2065
|
| 7.
|
Madara, J. L.,
and Stafford, J.
(1989)
J. Clin. Invest.
83,
724-727
|
| 8.
|
Colgan, S. P.,
Resnick, M. B.,
Parkos, C. A.,
Delp-Archer, C.,
McGuirk, D.,
Bacarra, A. E.,
Weller, P. F.,
and Madara, J. L.
(1994)
J. Immunol.
153,
2122-2129
|
| 9.
|
Stevens, A. C.,
Matthews, J.,
Andres, P.,
Baffis, V.,
Zheng, X. X.,
Chae, D. W.,
Smith, J.,
Strom, T. B.,
and Maslinski, W.
(1997)
Am. J. Physiol.
272,
G1201-G1208
|
| 10.
|
Kinugasa, T.,
Sakaguchi, T.,
Gu, X.,
and Reinecker, H. C.
(2000)
Gastroenterology
118,
1001-1011
|
| 11.
|
Furuse, M.,
Fujita, K.,
Hiiragi, T.,
Fujimoto, K.,
and Tsukita, S.
(1998)
J. Cell Biol.
141,
1539-1550
|
| 12.
|
Furuse, M.,
Hirase, T.,
Itoh, M.,
Nagafuchi, A.,
Yonemura, S.,
and Tsukita, S.
(1993)
J. Cell Biol.
123,
1777-1788
|
| 13.
|
Ando-Akatsuka, Y.,
Saitou, M.,
Hirase, T.,
Kishi, M.,
Sakakibara, A.,
Itoh, M.,
Yonemura, S.,
Furuse, M.,
and Tsukita, S.
(1996)
J. Cell Biol.
133,
43-47
|
| 14.
|
Furuse, M.,
Itoh, M.,
Hirase, T.,
Nagafuchi, A.,
Yonemura, S.,
and Tsukita, S.
(1994)
J. Cell Biol.
127,
1617-1626
|
| 15.
|
Itoh, M.,
Furuse, M.,
Morita, K.,
Kubota, K.,
Saitou, M.,
and Tsukita, S.
(1999)
J. Cell Biol.
147,
1351-1363
|
| 16.
|
Woods, D. F.,
and Bryant, P. J.
(1993)
Mech. Dev.
44,
85-89
|
| 17.
|
Jesaitis, L. A.,
and Goodenough, D. A.
(1994)
J. Cell Biol.
124,
949-961
|
| 18.
|
Anderson, J. M.
(1996)
Curr. Biol.
6,
382-384
|
| 19.
|
Itoh, M.,
Nagafuchi, A.,
Moroi, S.,
and Tsukita, S.
(1997)
J. Cell Biol.
138,
181-192
|
| 20.
|
Fanning, A. S.,
Jameson, B. J.,
Jesaitis, L. A.,
and Anderson, J. M.
(1998)
J. Biol. Chem.
273,
29745-29753
|
| 21.
|
Itoh, M.,
Morita, K.,
and Tsukita, S.
(1999)
J. Biol. Chem.
274,
5981-5986
|
| 22.
|
Wittchen, E. S.,
Haskins, J.,
and Stevenson, B. R.
(1999)
J. Biol. Chem.
274,
35179-35185
|
| 23.
|
Peeters, M.,
Geypens, B.,
Claus, D.,
Nevens, H.,
Ghoos, Y.,
Verbeke, G.,
Baert, F.,
Vermeire, S.,
Vlietinck, R.,
and Rutgeerts, P.
(1997)
Gastroenterology
113,
802-807
|
| 24.
|
Hilsden, R. J.,
Meddings, J. B.,
and Sutherland, L. R.
(1996)
Gastroenterology
110,
1395-1403
|
| 25.
|
Schmitz, H.,
Barmeyer, C.,
Fromm, M.,
Runkel, N.,
Foss, H. D.,
Bentzel, C. J.,
Riecken, E. O.,
and Schulzke, J. D.
(1999)
Gastroenterology
116,
301-309
|
| 26.
|
Grabstein, K. H.,
Eisenman, J.,
Shanebeck, K.,
Rauch, C.,
Srinivasan, S.,
Fung, V.,
Beers, C.,
Richardson, J.,
Schoenborn, M. A.,
Ahdieh, M.,
Johnson, L.,
Alderson, M. R.,
Watson, J. D.,
Anderson, D. M.,
and Giri, J. G.
(1994)
Science
264,
965-968
|
| 27.
|
Bamford, R. N.,
Grant, A. J.,
Burton, J. D.,
Peters, C.,
Kurys, G.,
Goldman, C. K.,
Brennan, J.,
Roessler, E.,
and Waldmann, T. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4940-4944
|
| 28.
|
Giri, J. G.,
Ahdieh, M.,
Eisenman, J.,
Shanebeck, K.,
Grabstein, K.,
Kumaki, S.,
Namen, A.,
Park, L. S.,
Cosman, D.,
and Anderson, D.
(1994)
EMBO J.
13,
2822-2830
|
| 29.
|
Burton, J. D.,
Bamford, R. N.,
Peters, C.,
Grant, A. J.,
Kurys, G.,
Goldman, C. K.,
Brennan, J.,
Roessler, E.,
and Waldmann, T. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4935-4939
|
| 30.
|
Anderson, D. M.,
Kumaki, S.,
Ahdieh, M.,
Bertles, J.,
Tometsko, M.,
Loomis, A.,
Giri, J.,
Copeland, N. G.,
Gilbert, D. J.,
Jenkins, N. A.,
Valentine, V.,
Shapiro, D. N.,
Morris, S. W.,
Park, L. S.,
and Cosman, D.
(1995)
J. Biol. Chem.
270,
29862-29869
|
| 31.
|
Sakai, T.,
Kusugami, K.,
Nishimura, H.,
Ando, T.,
Yamaguchi, T.,
Ohsuga, M.,
Ina, K.,
Enomoto, A.,
Kimura, Y.,
and Yoshikai, Y.
(1998)
Gastroenterology
114,
1237-1243
|
| 32.
|
Liu, Z.,
Geboes, K.,
Colpaert, S.,
D'Haens, G. R.,
Rutgeerts, P.,
and Ceuppens, J. L.
(2000)
J. Immunol.
164,
3608-3615
|
| 33.
|
Meijssen, M. A.,
Brandwein, S. L.,
Reinecker, H. C.,
Bhan, A. K.,
and Podolsky, D. K.
(1998)
Am. J. Physiol.
274,
G472-G479
|
| 34.
|
Ebert, E. C.
(1998)
Gastroenterology
115,
1439-1445
|
| 35.
|
Inagaki-Ohara, K.,
Nishimura, H.,
Mitani, A.,
and Yoshikai, Y.
(1997)
Eur. J. Immunol.
27,
2885-2891
|
| 36.
|
Lai, Y. G.,
Gelfanov, V.,
Gelfanova, V.,
Kulik, L.,
Chu, C. L.,
Jeng, S. W.,
and Liao, N. S.
(1999)
J. Immunol.
163,
5843-5850
|
| 37.
|
Lodolce, J. P.,
Boone, D. L.,
Chai, S.,
Swain, R. E.,
Dassopoulos, T.,
Trettin, S.,
and Ma, A.
(1998)
Immunity
9,
669-676
|
| 38.
|
Reinecker, H. C.,
and Podolsky, D. K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8353-8357
|
| 39.
|
Brown, D. A.,
and London, E.
(1997)
Biochem. Biophys. Res. Commun.
240,
1-7
|
| 40.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572
|
| 41.
|
Muehlhoefer, A.,
Saubermann, L. J.,
Gu, X.,
Luedtke-Heckenkamp, K.,
Xavier, R.,
Blumberg, R. S.,
Podolsky, D. K.,
MacDermott, R. P.,
and Reinecker, H. C.
(2000)
J. Immunol.
164,
3368-3376
|
| 42.
|
Reinecker, H. C.,
MacDermott, R. P.,
Mirau, S.,
Dignass, A.,
and Podolsky, D. K.
(1996)
Gastroenterology
111,
1706-1713
|
| 43.
|
Lisanti, M. P.,
Tang, Z.,
Scherer, P. E.,
Kubler, E.,
Koleske, A. J.,
and Sargiacomo, M.
(1995)
Mol. Membr. Biol.
12,
121-124
|
| 44.
|
Song, S. K.,
Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697
|
| 45.
|
Parton, R. G.,
and Simons, K.
(1995)
Science
269,
1398-1399
|
| 46.
|
Okamoto, T.,
Schlegel, A.,
Scherer, P. E.,
and Lisanti, M. P.
(1998)
J. Biol. Chem.
273,
5419-5422
|
| 47.
|
Stuart, R. O.,
and Nigam, S. K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6072-6076
|
| 48.
|
Stuart, R. O.,
Sun, A.,
Bush, K. T.,
and Nigam, S. K.
(1996)
J. Biol. Chem.
271,
13636-13641
|
| 49.
|
Nusrat, A.,
Parkos, C. A.,
Verkade, P.,
Foley, C. S.,
Liang, T. W.,
Innis-Whitehouse, W.,
Eastburn, K. K.,
and Madara, J. L.
(2000)
J. Cell Sci.
113,
1771-1781
|
| 50.
|
Chen, Y.,
Lu, Q.,
Schneeberger, E. E.,
and Goodenough, D. A.
(2000)
Mol. Biol. Cell
11,
849-862
|
| 51.
|
Sakakibara, A.,
Furuse, M.,
Saitou, M.,
Ando-Akatsuka, Y.,
and Tsukita, S.
(1997)
J. Cell Biol.
137,
1393-1401
|
| 52.
|
Wong, V.
(1997)
Am. J. Physiol.
273,
C1859-C1867
|
| 53.
|
Badizadegan, K.,
Dickinson, B. L.,
Wheeler, H. E.,
Blumberg, R. S.,
Holmes, R. K.,
and Lencer, W. I.
(2000)
Am. J. Physiol.
278,
G895-G904
|
| 54.
|
Van Itallie, C. M.,
Balda, M. S.,
and Anderson, J. M.
(1995)
J. Cell Sci.
108,
1735-1742
|
| 55.
|
Tsukamoto, T.,
and Nigam, S. K.
(1999)
Am. J. Physiol.
276,
F737-F750
|
| 56.
|
Kurihara, H.,
Anderson, J. M.,
and Farquhar, M. G.
(1995)
Am. J. Physiol.
268,
F514-F524
|
| 57.
|
Takeda, H.,
and Tsukita, S.
(1995)
Cell Struct. Funct.
20,
387-393
|
| 58.
|
Collares-Buzato, C. B.,
Jepson, M. A.,
Simmons, N. L.,
and Hirst, B. H.
(1998)
Eur J. Cell Biol.
76,
85-92
|
| 59.
|
Staddon, J. M.,
Herrenknecht, K.,
Smales, C.,
and Rubin, L. L.
(1995)
J. Cell Sci.
108,
609-619
|
| 60.
|
Tsukita, S.,
Furuse, M.,
and Itoh, M.
(2001)
Nat. Rev. Mol. Cell Biol.
2,
285-293
|
| 61.
|
Morita, K.,
Sasaki, H.,
Fujimoto, K.,
Furuse, M.,
and Tsukita, S.
(1999)
J. Cell Biol.
145,
579-588
|
| 62.
|
Morita, K.,
Furuse, M.,
Fujimoto, K.,
and Tsukita, S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
511-516
|
| 63.
|
Morita, K.,
Sasaki, H.,
Furuse, M.,
and Tsukita, S.
(1999)
J. Cell Biol.
147,
185-194
|
| 64.
|
Sonoda, N.,
Furuse, M.,
Sasaki, H.,
Yonemura, S.,
Katahira, J.,
Horiguchi, Y.,
and Tsukita, S.
(1999)
J. Cell Biol.
147,
195-204
|
| 65.
|
McCarthy, K. M.,
Skare, I. B.,
Stankewich, M. C.,
Furuse, M.,
Tsukita, S.,
Rogers, R. A.,
Lynch, R. D.,
and Schneeberger, E. E.
(1996)
J. Cell Sci.
109,
2287-2298
|
| 66.
|
Balda, M. S.,
Whitney, J. A.,
Flores, C.,
Gonzalez, S.,
Cereijido, M.,
and Matter, K.
(1996)
J. Cell Biol.
134,
1031-1049
|
| 67.
|
Tagaya, Y.,
Burton, J. D.,
Miyamoto, Y.,
and Waldmann, T. A.
(1996)
EMBO J.
15,
4928-4939
|
| 68.
|
Rosenberg, I. M.,
Goke, M.,
Kanai, M.,
Reinecker, H. C.,
and Podolsky, D. K.
(1997)
Am. J. Physiol.
273,
G824-G832
|
| 69.
|
Kirman, I.,
and Nielsen, O. H.
(1996)
Am. J. Gastroenterol.
91,
1789-1794
|
| 70.
|
Andres, P. G.,
Beck, P. L.,
Mizoguchi, E.,
Mizoguchi, A.,
Bhan, A. K.,
Dawson, T.,
Kuziel, W. A.,
Maeda, N.,
MacDermott, R. P.,
Podolsky, D. K.,
and Reinecker, H. C.
(2000)
J. Immunol.
164,
6303-6312
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Fumagalli, U. Pozzoli, R. Cagliani, G. P. Comi, S. Riva, M. Clerici, N. Bresolin, and M. Sironi
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions
J. Exp. Med.,
June 8, 2009;
206(6):
1395 - 1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kohler, T. Sakaguchi, B. P. Hurley, B. J. Kase, H.-C. Reinecker, and B. A. McCormick
Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage
Am J Physiol Gastrointest Liver Physiol,
July 1, 2007;
293(1):
G178 - G187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Howe, C. Reardon, A. Wang, A. Nazli, and D. M. McKay
Transforming Growth Factor-{beta} Regulation of Epithelial Tight Junction Proteins Enhances Barrier Function and Blocks Enterohemorrhagic Escherichia coli O157:H7-Induced Increased Permeability
Am. J. Pathol.,
December 1, 2005;
167(6):
1587 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Watson, C. J. Hoare, D. R. Garrod, G. L. Carlson, and G. Warhurst
Interferon-{gamma} selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores
J. Cell Sci.,
November 15, 2005;
118(22):
5221 - 5230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Kim, U. S. Sajjan, G. P. Krasan, and J. J. LiPuma
Disruption of Tight Junctions during Traversal of the Respiratory Epithelium by Burkholderia cenocepacia
Infect. Immun.,
November 1, 2005;
73(11):
7107 - 7112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, R. Dawson, I. J. Crane, and J. Liversidge
Leukocyte Diapedesis In Vivo Induces Transient Loss of Tight Junction Protein at the Blood-Retina Barrier
Invest. Ophthalmol. Vis. Sci.,
July 1, 2005;
46(7):
2487 - 2494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Mruk and C. Y. Cheng
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
Endocr. Rev.,
October 1, 2004;
25(5):
747 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Turksen and T.-C. Troy
Barriers built on claudins
J. Cell Sci.,
May 15, 2004;
117(12):
2435 - 2447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamauchi, T. Rai, K. Kobayashi, E. Sohara, T. Suzuki, T. Itoh, S. Suda, A. Hayama, S. Sasaki, and S. Uchida
Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins
PNAS,
March 30, 2004;
101(13):
4690 - 4694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yoo, A. Nichols, J. Mammen, I. Calvo, J. C. Song, R. T. Worrell, K. Matlin, and J. B. Matthews
Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins
Am J Physiol Cell Physiol,
August 1, 2003;
285(2):
C300 - C309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. R. Colegio, C. V. Itallie, C. Rahner, and J. M. Anderson
Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture
Am J Physiol Cell Physiol,
June 1, 2003;
284(6):
C1346 - C1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yoo, A. Nichols, J. C. Song, J. Mammen, I. Calvo, R. T. Worrell, J. Cuppoletti, K. Matlin, and J. B. Matthews
Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes
Am J Physiol Gastrointest Liver Physiol,
April 1, 2003;
284(4):
G703 - G712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Nunbhakdi-Craig, T. Machleidt, E. Ogris, D. Bellotto, C. L. White III, and E. Sontag
Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex
J. Cell Biol.,
September 3, 2002;
158(5):
967 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Edens, B. P. Levi, D. L. Jaye, S. Walsh, T. A. Reaves, J. R. Turner, A. Nusrat, and C. A. Parkos
Neutrophil Transepithelial Migration: Evidence for Sequential, Contact-Dependent Signaling Events and Enhanced Paracellular Permeability Independent of Transjunctional Migration
J. Immunol.,
July 1, 2002;
169(1):
476 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|